JP2017517255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517255A5
JP2017517255A5 JP2016568573A JP2016568573A JP2017517255A5 JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5 JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
jelly
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032078 external-priority patent/WO2015179711A1/en
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A JP2017517255A (ja) 2017-06-29
JP2017517255A5 true JP2017517255A5 (cg-RX-API-DMAC7.html) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (cg-RX-API-DMAC7.html)
EP (1) EP3146039A4 (cg-RX-API-DMAC7.html)
JP (2) JP2017517255A (cg-RX-API-DMAC7.html)
AU (2) AU2015264025A1 (cg-RX-API-DMAC7.html)
WO (1) WO2015179711A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1933852B1 (en) 2005-09-27 2018-12-19 TissueTech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
JP6640826B2 (ja) 2014-07-08 2020-02-05 ミメディクス グループ インコーポレイテッド 微粒子化ワルトン膠質
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
TW201642914A (zh) 2015-02-23 2016-12-16 組織科技股份有限公司 用於治療眼部疾病及失調的裝置及方法
EP3297645A4 (en) 2015-05-20 2018-12-12 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
KR102354954B1 (ko) 2016-04-04 2022-01-24 오메자 엘엘씨 어유 국소 조성물
CA3029233A1 (en) * 2016-06-24 2017-12-28 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
EP3684382A4 (en) * 2017-09-19 2021-06-09 Gary M. Petrucci AMNION TISSUE PREPARATIONS AND METHOD OF USE
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
AU2018351314A1 (en) * 2017-10-19 2020-03-19 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
CA3148631A1 (en) * 2019-08-08 2021-02-11 Tissue Regeneration Therapeutics Inc. Perivascular lysates and uses thereof
US20230047934A1 (en) * 2020-03-12 2023-02-16 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
WO2022159789A1 (en) * 2021-01-25 2022-07-28 Biostem Technologies, Inc. Two-part clotting composition and methods of making and using thereof
EP4511046A1 (en) * 2022-04-20 2025-02-26 Biostem Technologies, Inc. Multi-part processed human amniotic composition and methods of making and using thereof for treatment of peyronie's disease
EP4561595A2 (en) * 2022-07-26 2025-06-04 Biostem Technologies, Inc. Human umbilical cord compositions and methods for intra-articular therapy
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US8105634B2 (en) * 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
JP5427237B2 (ja) * 2008-10-10 2014-02-26 イストセル,エセ.エレ. ヒト臍帯のウォートン・ジェリー由来の新規な生物材料
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
MX2012011354A (es) * 2010-03-30 2012-11-30 Histocell Sl Nuevo biomaterial procedente de gelatina de wharton de cordon umbilical.
AU2012217975B2 (en) * 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
CA2826433C (en) * 2011-02-14 2022-05-31 Brenda S. Morse Micronized placental tissue compositions and methods of making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
HUE056817T2 (hu) * 2011-12-30 2022-03-28 Amit Patel Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
EP2884944B1 (en) * 2012-08-15 2020-10-07 MiMedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
EP3043771A4 (en) * 2013-09-10 2017-05-03 MIMEDX Group Inc. Cosmetic uses of molded placental compositions

Similar Documents

Publication Publication Date Title
JP2017517255A5 (cg-RX-API-DMAC7.html)
JP5298307B2 (ja) 半合成の血小板ゲル及びその調製方法
AU2015287920A8 (en) Micronized Wharton's Jelly
JP2017525671A5 (cg-RX-API-DMAC7.html)
JP2016216487A5 (cg-RX-API-DMAC7.html)
ME02868B (me) POSTUPCI, CEV, l UREĐAJ ZA DOBIJANJE KOMPOZICIJE ZA ZARASTANJE RANA
JP2013527217A5 (cg-RX-API-DMAC7.html)
WO2013096792A1 (en) Method for repairing or replacing damaged tissue
MX388111B (es) Metodo y composicion para producir agentes regenerativos anti-inflamatorios/anti-catabolicos mejorados a partir de fluido fisiologico autologo.
RU2016130161A (ru) Покрытия для медицинских изделий
Cheng et al. Development of injectable graphene oxide/laponite/gelatin hydrogel containing Wharton's jelly mesenchymal stem cells for treatment of oxidative stress-damaged cardiomyocytes
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
US9821027B2 (en) Method for regenerating cartilage comprising applying a monovalent metal salt of alginic acid and SDF-1
HRP20161138T1 (hr) Farmaceutski pripravak za oralnu primjenu
JP2017507145A5 (cg-RX-API-DMAC7.html)
CN104448356A (zh) 一种空白plga微球及制备方法
JP2013173780A5 (cg-RX-API-DMAC7.html)
US10111904B2 (en) Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor
Zhang et al. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
US10583216B2 (en) Scaffold compositions for tissue repair
CN101401971B (zh) 胶原球形多孔颗粒材料及其制备方法和装置
CN104524633B (zh) 一种基于肌肉的神经支架及其制备方法
LT2014117A (lt) Trimatis porėtas celiuliozės karkasas kaulo inžinerijai ir jo gavimo būdas
US20220143268A1 (en) Novel bone putty compositions and methods of use thereof
MX380536B (es) Composicion y metodo para tratar la enfermedad de chagas.